doi: 10.1089/jop.Wintertime is in full effect, but if you're ready for spring to blossom, you're not alone. (2018) ‘Is the Eye an Extension of the Brain in Central Nervous System Disease?’, Journal of Ocular Pharmacology and Therapeutics, 34(1–2), pp. Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease. et al. (2017) ‘Real-time imaging of single neuronal cell apoptosis in patients with glaucoma.’, Brain : a journal of neurology, 140(6), pp. (2016) ‘Eyeing the brain’, Acta Neuropathologica.
Professor Peter Stalmans (University Leuven, Belgium)Ĭordeiro, M. Professor Tom Gardner (University of Michigan). Professor Stefano Gandolfi (Parma, Italy). Professor John Flanagan (Waterloo, Canada). Professors Crawford Downs and Chris Girkin (Birmingham, Alabama). Professor Alastair Barber (University of Pennsylvania). Oculoplastics, vitreoretinal, cataracts, genetic, paediatric. Macular - age-related macular degeneration (AMD), diabetic macular oedema (DMO), polypoidal choroidal vasculopathy, macular telangiectasia (MacTel). Glaucoma - primary open angle glaucoma (POAG), acute angle glaucoma, ocular hypertension. By researching methods of diagnosis and therapeutic treatments we are able to improve patient-care in the community positively impacting future generations diagnosed with ocular diseases to prevent blindness and avoid disability. We seek opportunities to investigate new therapeutic treatments for ocular diseases, including discovering and developing novel modes of drug delivery and improved treatment strategies.Ĭurrently in the UK there is estimated to be around 1.58 to 2.31 million people affected with sight-loss and blindness as a result of ocular diseases such as age-related macular degenerative disease (AMD), cataract, diabetic retinopathy and glaucoma. Our aim is to optimise the establishment of new diagnostic methods of early disease and identify early markers of cell processes in neurodegenerative disease. Research and Career Development Committee. Personal Review and Development Plan (PRDP). Equality, diversity and disability support. Hamlyn Winter School on Surgical Imaging and Vision. Digital Maternity Leaders (Foundations in Digital Health Leadership Programme). Oesophago-gastric Surgery: Benign conditions of the oesophagus and stomach and OG emergencies. Casualty Reception and Initial Management. Medical Robotics and Image-Guided Intervention. Imperial Experimental Cancer Medicine Centre (ECMC). London General Surgical Skills Programme. Imperial College Healthcare Tissue Bank. Imperial Experimental Cancer Medicine Centre. Patient Safety Translational Research Centre. Extracorporeal and advanced life support. Microvesicles in Acute Respiratory Distress Syndrome. Memory and Memories in Perioperative Care. Cardiothoracic and Advanced Life Support. Anaesthetics, Pain Medicine and Intensive Care. Translational Cancer Medicine and Imaging. Pancreatic Cancer Chemoresistance and Clinical Trials. Gynaecological cancer - surgery and translational research. 
Developmental Therapeutics and Cancer Immunotherapy.Cancer Metabolism and Systems Toxicology.Androgen Signalling and Prostate Cancer.Translational Research - Bench to Bedside.Translational Data analytics and informatics in healthcare.Translational Colorectal Research Laboratory.St Mark’s Familial Colorectal Cancer Group.Simulation and Modelling in Medicine and Surgery.Section of Hepatopancreatobiliary Surgery.Safety and effectiveness in joint replacement.NIHR London In Vitro Diagnostics Co-operative.Neuroergonomics and Perception Laboratory.London Aortic Mechanobiology Working Group.
Imperial College Ophthalmology Research Group.Centre for Engagement and Simulation Science.Cancer Screening and Prevention Research Group (CSPRG).Biomarker Assessment, Validation, and Translation.Our relationship with the NIHR Imperial BRC.Department of Surgery and Cancer Overview.Search Imperial Search Department of Surgery and Cancer Section Navigation
0 kommentar(er)
